Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1. (Q37068522)
Jump to navigation
Jump to search
scholarly article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1. |
scholarly article |
Statements
1 reference
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1. (English)
1 reference
Robert C Gallo
1 reference
Gregory Melikyan
1 reference
Alonso Heredia
1 reference
Olga Latinovic
1 reference
Marv Reitz
1 reference
Nhut Le
1 reference
Robert R Redfield
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference